Literature DB >> 29399518

Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation.

Younes Jahangiri1, Timothy Kerrigan1, Lei Li1, Dominik Prosser1, Anantnoor Brar1, Johnathan Righetti1, Ryan C Schenning1, John A Kaufman1, Khashayar Farsad1.   

Abstract

BACKGROUND: To identify risk factors of stent graft thrombosis after transjugular intrahepatic portosystemic shunt (TIPS) creation.
METHODS: Patients who underwent TIPS creation between June 2003 and January 2016 and with follow-up assessing stent graft patency were included (n=174). Baseline comorbidities, liver function, procedural details and follow-up liver function tests were analyzed in association with hazards of thrombosis on follow-up. Competing risk cox regression models were used considering liver transplant after TIPS creation as the competing risk variable.
RESULTS: One-, 2- and 5-year primary patency rates were 94.1%, 91.7% and 78.2%, respectively. Patient age [sub-hazard ratio (sHR): 1.13; P=0.001], body mass index (BMI) <30 (sHR: 33.08; P=0.008) and a higher post-TIPS portosystemic pressure gradient (sHR: 1.14; P=0.023) were significantly associated with TIPS thrombosis in multivariate analysis. A higher rate of TIPS thrombosis was observed in those for whom the procedure was clinically unsuccessful (P=0.014). A significant increase in incidence of thrombosis was noted with increasing tertiles of post-TIPS portosystemic gradients (P value for trend=0.017).
CONCLUSIONS: Older age, lower BMI and higher post-TIPS portosystemic gradients were associated with higher hazards of shunt thrombosis after TIPS creation using stent grafts. Higher rates of shunt thrombosis were seen in patients for whom TIPS creation was clinically unsuccessful. The association between TIPS thrombosis and higher post-TIPS portosystemic gradients may indicate impaired flow through the shunt, a finding which may be technical or anatomic in nature and should be assessed before procedure completion.

Entities:  

Keywords:  Transjugular intrahepatic portosystemic shunt (TIPS); Viatorr; portal hypertension; stent graft; thrombosis

Year:  2017        PMID: 29399518      PMCID: PMC5778524          DOI: 10.21037/cdt.2017.10.03

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  24 in total

Review 1.  Management of shunt dysfunction in the era of TIPS endografts.

Authors:  Timothy W I Clark
Journal:  Tech Vasc Interv Radiol       Date:  2008-12

2.  No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.

Authors:  Ibrahim Akin; Ralph Tölg; Matthias Hochadel; Martin W Bergmann; Ahmed A Khattab; Steffen Schneider; Jochen Senges; Karl-Heinz Kuck; Gert Richardt; Christoph A Nienaber
Journal:  JACC Cardiovasc Interv       Date:  2012-02       Impact factor: 11.195

Review 3.  Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?

Authors:  Jonel Trebicka
Journal:  J Hepatol       Date:  2016-10-29       Impact factor: 25.083

4.  Transjugular portal venography and radiologic portacaval shunt: an experimental study.

Authors:  J Rösch; W N Hanafee; H Snow
Journal:  Radiology       Date:  1969-04       Impact factor: 11.105

5.  The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.

Authors:  M Rössle; V Siegerstetter; W Euringer; M Olschewski; J Kromeier; K Kurz; M Langer
Journal:  Acta Radiol       Date:  2006-09       Impact factor: 1.990

Review 6.  The history and future of transjugular intrahepatic portosystemic shunt: food for thought.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

Review 7.  Causes of TIPS dysfunction.

Authors:  Marco Cura; Alejandro Cura; Rajeev Suri; Fadi El-Merhi; Jorge Lopera; Ghazwan Kroma
Journal:  AJR Am J Roentgenol       Date:  2008-12       Impact factor: 3.959

8.  Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years.

Authors:  Pieter C J ter Borg; Mirjam Hollemans; Henk R Van Buuren; Frank P Vleggaar; Michael Groeneweg; Wim C J Hop; Johan S Laméris
Journal:  Radiology       Date:  2004-03-24       Impact factor: 11.105

9.  Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials.

Authors:  Xingshun Qi; Yulong Tian; Wei Zhang; Zhiping Yang; Xiaozhong Guo
Journal:  Therap Adv Gastroenterol       Date:  2016-10-20       Impact factor: 4.409

10.  Transjugular Intrahepatic Portosystemic Shunt Dysfunction: Concordance of Clinical Findings, Doppler Ultrasound Examination, and Shunt Venography.

Authors:  Joshua M Owen; Ron Charles Gaba
Journal:  J Clin Imaging Sci       Date:  2016-07-18
View more
  2 in total

1.  Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization.

Authors:  Holger Goessmann; Verna Schuffenhauer; Arne Kandulski; Kilian Weigand; Ernst-Michael Jung; Wibke Uller; Gregor Scharf; Cristian Stroszczynski; Niklas Verloh
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

2.  Quantitative analysis of in-TIPS thrombosis in abdominal CT.

Authors:  Simon Bernatz; Inga Weitkamp; Jan-Erik Scholtz; Vitali Koch; Leon D Grünewald; Christoph Mader; Jörg Ackermann; Moritz H Albrecht; Simon S Martin; Thomas J Vogl; Scherwin Mahmoudi
Journal:  Eur J Radiol Open       Date:  2022-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.